Skip to main content
Get started

FISH: An Increasingly Demanded Tool

Tracking # 20-556816

$15.00

5 (3 ratings)
Learn more
Educator 4CEUINC BY CONTINUING EDUCATION UNLIMITED
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

This Intermediate Level course reviews a brief background of Fluorescence in situ hybridization (FISH), and discusses its role in diagnosing hematologic malignancies & non-hematologic malignancies

Subject areas

This course counts toward the state boards and subject areas below.

American Board of Clinical Chemistry

Clinical Chemistry Diplomate

2h Category 1

Molecular Diagnostics Diplomate

2h Category 1

Toxicological Chemistry Diplomate

2h Category 1

Florida Board of Clinical Laboratory Personnel

Clinical Laboratory Director

2h General (Cytogenetics)

Clinical Laboratory Supervisor

2h General (Cytogenetics)

Clinical Laboratory Technician

2h General (Cytogenetics)

Clinical Laboratory Technologist

2h General (Cytogenetics)

Public Health Director

2h General (Cytogenetics)

Public Health Supervisor

2h General (Cytogenetics)

Public Health Technician

2h General (Cytogenetics)

Public Health Technologist

2h General (Cytogenetics)

Louisiana State Board of Medical Examiners - Clinical Lab Personnel

Cytotechnologist

2h Continuing Education for Clinical Laboratory Personnel

Generalist

2h Continuing Education for Clinical Laboratory Personnel

Specialist

2h Continuing Education for Clinical Laboratory Personnel

Technician

2h Continuing Education for Clinical Laboratory Personnel

Tennessee Medical Laboratory Board

Laboratory Personnel

2h Continuing education pertaining to laboratory technology or laboratory management

Disclosure statements

At the end of this course the learner will be able to:

  1. Recall a brief background of Fluorescence in situ hybridization (FISH)
  2. Discuss FISH’s role in diagnosing Hematopoietic Malignancies including leukemia, multiple myeloma (MM), and Myelodysplastic Syndromes (MDS)
  3. Discuss FISH’s role in diagnosing Non-Hematopoietic Malignancies (solid tumors) including lung cancer, prostate cancer, breast cancer, and melanoma
  4. Briefly discuss the progress in FISH methodology.

Learner Feedback